Home Mainline IPOs Emcure Pharma IPO
Orion Industries logo

Emcure Pharma IPO

Open MainLine
BSE,NSE 03 July - 05 July 2024
Emcure Pharmaceuticals Limited IPO is a book build issue of 1952.03 Cr. The issue is a combination of fresh issue of 7936507 shares aggregating to 800 Cr and offer for sale of 11428839 shares aggregating to 1152.03 Cr. Emcure Pharmaceuticals Limited IPO opened for subscription on Jul 03, 2024 and closed on Jul 05, 2024. The allotment for the this IPO was finalized on Jul 08, 2024. IPO was listed on NSE and BSE on Jul 10, 2024. Emcure Pharmaceuticals Limited IPO is set issue price band at ₹960 to ₹1008 per share.

Current GMP

₹0 (0.00%)

Price Band

₹ 960 – 1008

Lot Size

14

Issue Size

₹1952.03 Cr

Minimum Investment

₹14112 (14 Shares)

Listing Date

10 July 2024

Subscription

67.87x

About the Company

Incorporated in 1981, Emcure Pharmaceuticals Limited is a prominent Indian pharmaceutical company that develops, manufactures, and globally markets a diverse range of pharmaceutical products across several major therapeutic areas. 

As of September 2023, Emcure ranks 13th in domestic sales among Indian pharmaceutical companies and holds the 4th largest market share in its covered markets. The company has led the gynaecology and HIV antiviral therapeutic areas for the same period.

In the first half of FY 2023, sales in India accounted for 50.84% of Emcure's total revenue, while for the entire FY 2023, this figure was 53.16%. Between September 2019 and September 2023, Emcure’s domestic sales grew at a CAGR of 10.80%, surpassing the overall growth of the Indian pharmaceutical market.

Emcure employs 552 scientists and operates five research facilities in India, having filed over 1,800 documents globally, including 204 in the EU and 133 in Canada. The company boasts 201 granted patents, 33 pending applications, and 102 drug master files.

The company's 13 manufacturing facilities in India produce a variety of pharmaceutical and biopharmaceutical products. Its marketing and distribution network in India is supported by over 5,000 field personnel and stockists, served by 37 carry-and-forward agents, ensuring a robust interaction with healthcare providers nationwide.

Peer Details

The companies considered by Emcure Pharmaceuticals as its peers include: 

  1. Dr. Reddy's Laboratories Limited
  2. Cipla Limited
  3. Alkem Laboratories Limited
  4. Torrent Pharmaceuticals Limited
  5. Mankind Pharma Limited
  6. Abbott India Limited
  7. J. B. Chemicals & Pharmaceuticals Limited

Promoters

  1. Satish Mehta
  2. Sunil Mehta


Promoters Holding

Holding Pre Issue

98.90%

Holding Post Issue

78.24%

Objects of the Issue

 The company plans to allocate the net proceeds from the issuance to the following purposes: 

  1. Repayment and/or prepayment of certain outstanding borrowings.
  2. General corporate purposes.

Address / Contact Info

Emcure Pharmaceuticals Limited
Plot No. P-1 and P-2,
IT-BT Park, Phase II, M.I.D.C.,
Hinjawadi, Pune -411 057
Phone: +91 20 3507 0033
Email: investors@emcure.co.in
Website: https://www.emcure.com

IPO Snapshot

Face Value₹10 per share
Price Band₹ 960 – 1008
Lot Size14
Issue TypeBook-building IPO
Sale Type
Fresh Issue₹ 800.00 Cr
Offer for Sale₹ 1,152.03 Cr
Total Issue Size₹ 1,952.03 Cr
Listing AtBSE,NSE
Employee Discount90
Industry
Sector
QIB Quota19.78%
BNII Quota9.89%
SNII Quota4.94%
Retail Quota34.61%

Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.

Frequently Asked Questions

Everything you need to know before applying to an IPO.

Emcure Pharma IPO is a Book-building IPO worth ₹1952.03 crores. The price band is ₹960 to 1008 per share. The IPO opens on Wed, Jul 3, 2024 and closes on Fri, Jul 5, 2024. It will be listed on BSE and NSE. MUFG Intime India Private Limited ((Link Intime) is the registrar.

The Emcure Pharma IPO opens on Wed, Jul 3, 2024 and closes on Fri, Jul 5, 2024

Emcure Pharma IPO Price Band is ₹960 to 1008.

Emcure Pharma IPO lot size is 14, and the minimum amount required for application is ₹14112.

The minimum investment for Emcure Pharma IPO is approximately ₹14112 based on the upper price band.

To apply for the Emcure Pharma IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of Fri, Jul 5, 2024. After submission, funds are blocked until the basis of allotment of Emcure Pharma IPO is finalised.

Emcure Pharma IPO issue size is ₹1952.03 crores.

Emcure Pharma IPO allotment date is Sat, Jun 27, 2026.

The registrar for Emcure Pharma IPO is MUFG Intime India Private Limited ((Link Intime). Investors can go to MUFG Intime India Private Limited ((Link Intime) website for IPO allotment status, refund processing, and other queries related to Emcure Pharma IPO through their official website or helpline.

The Emcure Pharma IPO GMP (Grey Market Premium) is ₹300 as of Wed, Jul 10, 2024. Based on the upper price band of ₹1008 per share, the estimated Emcure Pharma IPO listing price is ₹1308, indicating a potential listing gain of approximately 31% over the issue price.